abstract |
The present invention relates to tert-butyl (S)-2-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-oxo-2,5-diazaspiro[ 3.4] to the solid phase form of octane-5-carboxylate, pharmaceutical compositions thereof, methods for their preparation and uses. |